Mallinckrodt plc, a leading global biopharmaceutical company, today announced publication of results of its Phase 1b clinical trial of StrataGraft, ...
Mallinckrodt publishes results of StrataGraft regenerative tissue Phase 1b study – News-Medical.net
ByGoogle News
Aug 16, 2019